Nalaganje...
Beefing up Prostate Cancer Therapy with Performance-Enhancing (Anti-) Steroids
In the May 26th issue of the New England Journal of Medicine, de Bono et al. report that the inhibition of androgen synthesis by abiraterone acetate prolonged the survival of men with prostate cancer previously treated by androgen suppression.
Shranjeno v:
| izdano v: | Cancer Cell |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2011
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4479125/ https://ncbi.nlm.nih.gov/pubmed/21741594 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccr.2011.06.019 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|